|
UBE2O expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.21940000108856E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.34849999950038E-08 |
| Normal-vs-Stage2 |
5.629900E-02 |
| Normal-vs-Stage3 |
3.968700E-04 |
| Normal-vs-Stage4 |
3.765000E-04 |
| Stage1-vs-Stage2 |
8.998400E-02 |
| Stage1-vs-Stage3 |
5.647000E-01 |
| Stage1-vs-Stage4 |
9.251200E-01 |
| Stage2-vs-Stage3 |
3.647200E-01 |
| Stage2-vs-Stage4 |
2.073600E-01 |
| Stage3-vs-Stage4 |
6.226400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11110000000636E-06 |
| Normal-vs-AfricanAmerican |
2.50379999999772E-06 |
| Normal-vs-Asian |
4.136500E-02 |
| Caucasian-vs-AfricanAmerican |
8.719800E-03 |
| Caucasian-vs-Asian |
8.999700E-02 |
| AfricanAmerican-vs-Asian |
1.776200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.12169999999468E-05 |
| Normal-vs-Female |
4.49070003405438E-10 |
| Male-vs-Female |
5.561600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.140280E-02 |
| Normal-vs-Age(41-60Yrs) |
1.31189999996728E-06 |
| Normal-vs-Age(61-80Yrs) |
4.40310000016098E-07 |
| Normal-vs-Age(81-100Yrs) |
1.464020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.260200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.879800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.202800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.711200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.773000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.963400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.10130004904852E-09 |
| Normal-vs-Grade 2 |
6.3995999999289E-07 |
| Normal-vs-Grade 3 |
1.183540E-04 |
| Normal-vs-Grade 4 |
2.46469999999333E-05 |
| Grade 1-vs-Grade 2 |
1.159660E-04 |
| Grade 1-vs-Grade 3 |
2.24829999999621E-05 |
| Grade 1-vs-Grade 4 |
2.284000E-02 |
| Grade 2-vs-Grade 3 |
3.258200E-01 |
| Grade 2-vs-Grade 4 |
1.874000E-01 |
| Grade 3-vs-Grade 4 |
6.140100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.209420E-04 |
| Normal-vs-ccB subtype |
1.72545000000079E-05 |
| ccA subtype-vs-ccB subtype |
2.179200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25429999999305E-05 |
| Normal-vs-N1 |
3.197800E-02 |
| N0-vs-N1 |
6.272800E-01 |
|
|
